Palta secures £72m Series B funding led by VNV Global to scale health products
The London-based health technology company has closed a Series B financing round backed by VNV Global and Target Global.
Palta operates as a health and well-being technology company that develops consumer-centric preventive healthcare applications. Its portfolio includes popular digital products such as Flo.Health, Simple Fasting, and Zing Fitness Coach.
Palta has secured £72m in a Series B funding round led by VNV Global. The financing also saw participation from Target Global alongside other existing and new investors.
The newly acquired capital will be deployed to scale the company product offerings within the health and well-being sector. Palta operates a diverse ecosystem of preventive health applications, including Flo.Health and Simple Fasting, serving millions of active users globally.
The latest investment follows a period of rapid expansion for the London-based technology firm, which utilises its proprietary Palta Brain platform to develop and accelerate the growth of digital wellness products.
From the founder
"Stemming from my passion for building products which positively impact millions globally, Palta collaborates with those who share our values and vision. Palta Brain platform, the foundational powerhouse that drives our consumer digital apps, allows for much faster scaling of both products that we envisage internally, as well as those that come to us from the market. This can be seen clearly in our 10x growth in two years alone."
Yuri Gurski
CEO and founder at Palta
Investor perspective
"Mobile and preventative health services are the future of the health industry,"
Per Brillioth
CEO, VNV Global
Use of funds
- 01Continue product development
